Aptus Pharma Limited IPO

Apply 0
Avoid 0

Closing in

Days
Hours
Mins
Secs

Don't Miss It! Mark Your Calender Now:


Aptus Pharma Limited is specializes in the marketing and distribution of pharmaceutical formulations. Operating under a contract manufacturing model, Aptus Pharma does not own manufacturing facilities but collaborates with several third-party manufacturers. Its product portfolio spans various therapeutic categories, including anti-infectives, gastrointestinal drugs, anti-diabetic, cardiovascular, and wellness products.

Product Portfolio and Divisions

Aptus Pharma’s diverse product portfolio is structured into four key divisions:

1. Aptus Pharma (Pioneer Division): Focuses on acute therapies such as anti-infectives, pain management, antacids, and gastrointestinal drugs.

2. Aptus CD Care (Cardiac Diabetic Division): Dedicated to chronic therapies like anti-hypertensives, anti-diabetic, and lipid-lowering treatments.

3. Aptus Wellcare (Wellcare Division): Offers wellness and nutraceutical products, OTC formulations, and personal care items.

4. Aptus Global (Export Division): Focuses on exploring and developing export opportunities, particularly in emerging markets. Export activities are still in progress.

Manufacturing and Supply Chain

The company follows an asset-light model and does not own manufacturing facilities. It works with third-party contract manufacturers in Gujarat, Himachal Pradesh, and Uttarakhand. Aptus Pharma ensures strict adherence to quality standards, with WHO-GMP certifications required for all manufacturing partners. The company operates centrally located warehouses in Ahmedabad to ensure consistent inventory management and product availability.

Sales and Distribution Network

Aptus Pharma has a well-established distribution network across India, with over 125 direct and sub-distributors and a dedicated sales team. Gujarat is the company’s largest market, and it plans to expand into Maharashtra, Goa, Rajasthan, Madhya Pradesh, and Chhattisgarh. The company is also working to begin exporting its products to foreign markets.

Growth and Market Reach

Since its inception, Aptus Pharma has expanded its portfolio from 25 products to over 194, with a presence across Gujarat and other states. The company’s flagship brand, “Chilkul,” was recognized as a Best Healthcare Brand by The Economic Times in 2021-22. Aptus Pharma’s products are marketed through more than 75 brands, distributed through both physical retail and online platforms such as 1MG and PharmEasy.

Objects of the Aptus Pharma Limited IPO:

Company proposes to utilize the Net Proceeds from the issue towards the following objects: 1. Capital Expenditure for Office Premises with furniture and Industrial Racks (₹1.62 cr) 2. Working Capital (₹8 cr) 3. General Corporate Purpose
DRHP of Aptus Pharma Limited IPO
RHP of Aptus Pharma Limited IPO

Aptus Pharma Limited IPO Details:

Open Date: Sep 23 2025
Close Date: Sep 25 2025
Total Shares: 18,60,000
Face Value: ₹ 10 Per Equity Share
Issue Type: Book Building
Issue Size: 13.02 Cr.
Lot Size: 2000 Shares
Issue Price: ₹ 65-70 Per Equity Share
Listing At: BSE SME
Listing Date: Sep 30 2025

Promoters And Management:

1. Mr. Tejash Maheshchandra Hathi (45) is the Managing Director and a Promoter of the Company. He holds an MBA in Marketing and Management Accounting from Saurashtra University and is pursuing a Ph.D. in Management. With over 20 years of experience in the pharmaceutical industry, he has been with the Company since 2010 and became Managing Director in January 2024. He oversees the company’s day-to-day operations. 2. Mr. Chetan Shantilal Lalseta (48) is a Non-Executive Director and Promoter with over 20 years of experience as a Consultant Dermatologist. He completed his M.B.B.S. and M.D. (Skin & V.D.) from Saurashtra University. He practices at Shraddha Hospital and serves as a consultant at Wockhardt and Sterling Hospitals. He is also a visiting faculty member and involved in various healthcare management ventures. 3. Mrs. Jyotiben Chandarana (67) has been a Non-Executive Director since May 2024. She has experience in the transport and logistics industry, having worked in admin and accounts departments at Trishul Transport and Prashant Transport. She is actively involved in social and religious activities

Financials of Aptus Pharma Limited IPO: 

To be updated shortly

Comparison With Peers:

To be updated shortly

Lead Manager of Aptus Pharma Limited IPO:

  1. Interactive Financial Services

Registrar of Aptus Pharma Limited IPO:

  1. Bigshare Services Private Limited

Discussion on Aptus Pharma Limited IPO:

Leave a Reply